Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry

被引:51
作者
Chiu, Po-Lin [1 ]
Bou-Assaf, George M. [2 ]
Chhabra, Ekta Seth [2 ]
Chambers, Melissa G. [1 ]
Peters, Robert T. [2 ]
Kulman, John D. [2 ]
Walz, Thomas [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[2] Biogen, Cambridge, MA USA
[3] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
COAGULATION-FACTOR-VIII; AFFINITY BINDING-SITE; VONWILLEBRAND-FACTOR; C2; DOMAIN; ANTIBODY; DISEASE;
D O I
10.1182/blood-2015-04-641688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Association with the D'D3 domain of von Willebrand factor (VWF) stabilizes factor VIII (FVIII) in the circulation and maintains it at a level sufficient to prevent spontaneous bleeding. We used negative-stain electron microscopy (EM) to visualize complexes of FVIII with dimeric and monomeric forms of the D'D3 domain. The EM averages show that FVIII interacts with the D'D3 domain primarily through its C1 domain, with the C2 domain providing a secondary attachment site. Hydrogen-deuterium exchange mass spectrometry corroborated the importance of the C1 domain in D'D3 binding and implicates additional surface regions on FVIII in the interaction. Together, our results establish that the C1 domain is the major binding site on FVIII for VWF, reiterate the importance of the a3 acidic peptide in VWF binding, and suggest that the A3 and C2 domains play ancillary roles in this interaction.
引用
收藏
页码:935 / 938
页数:4
相关论文
共 20 条
[1]   Factor VIII C1 Domain Spikes 2092-2093 and 2158-2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake [J].
Bloem, Esther ;
van den Biggelaar, Maartje ;
Wroblewska, Aleksandra ;
Voorberg, Jan ;
Faber, Johan H. ;
Kjalke, Marianne ;
Stennicke, Henning R. ;
Mertens, Koen ;
Meijer, Alexander B. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (41) :29670-29679
[2]  
FOSTER PA, 1987, J BIOL CHEM, V262, P8443
[3]   FACTOR-VIII BINDS TO VONWILLEBRAND-FACTOR VIA ITS MR-80000 LIGHT CHAIN [J].
HAMER, RJ ;
KOEDAM, JA ;
BEESERVISSER, NH ;
BERTINA, RM ;
VANMOURIK, JA ;
SIXMA, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 166 (01) :37-43
[4]   The International Society on Thrombosis and Haematosis von Willebrand Disease Database: An Update [J].
Hampshire, Daniel J. ;
Goodeve, Anne C. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (05) :470-479
[5]   The Utility of Hydrogen/Deuterium Exchange Mass Spectrometry in Biopharmaceutical Comparability Studies [J].
Houde, Damian ;
Berkowitz, Steven A. ;
Engen, John R. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (06) :2071-2086
[6]  
Jacquemin M, 2000, BLOOD, V95, P156
[7]   A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIIIC1 domain reduce factor VIII binding to von Willebrand factor [J].
Jacquemin, M ;
Lavend'homme, R ;
Benhida, A ;
Vanzieleghem, B ;
d'Oiron, R ;
Lavergne, JM ;
Brackmann, HH ;
Schwaab, R ;
VandenDriessche, T ;
Chuah, MKL ;
Hoylaerts, M ;
Gilles, JGG ;
Peerlinck, K ;
Vermylen, J ;
Saint-Remy, JMR .
BLOOD, 2000, 96 (03) :958-965
[8]   THE INTERACTION BETWEEN HUMAN BLOOD-COAGULATION FACTOR-VIII AND VONWILLEBRAND-FACTOR - CHARACTERIZATION OF A HIGH-AFFINITY BINDING-SITE ON FACTOR-VIII [J].
LEYTE, A ;
VERBEET, MP ;
BRODNIEWICZPROBA, T ;
VANMOURIK, JA ;
MERTENS, K .
BIOCHEMICAL JOURNAL, 1989, 257 (03) :679-683
[9]  
LEYTE A, 1991, J BIOL CHEM, V266, P740
[10]  
NISHINO M, 1989, BLOOD, V74, P1591